Management of radioiodine ablation therapy in haemodialysis patients with thyroid cancer: a case series of two patients

Abstract Background Radioiodine (131I) therapy in treatment of thyroid cancer, has a biological clearance that is significantly reduced in end-stage kidney disease (ESKD), leading to increased radiation exposure and potential myelotoxicity. For ESKD patients on haemodialysis (HD), there is no standa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Raymond Lin, Alessandra L. Malaroda, William J. Ryder, Veronica C. K. Wong, Nikki L. Wong
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-07-01
Edice:	BMC Nephrology
Témata:	Haemodialysis Radioiodine therapy Thyroid cancer Nuclear medicine Case series
On-line přístup:	https://doi.org/10.1186/s12882-025-04348-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!